|
1
|
Pipitone G, Iaria C, Granata G, Cascio A, Maraolo AE. Which trials do we need? Fidaxomicin plus either intravenous metronidazole or tigecycline versus vancomycin plus either intravenous metronidazole or tigecycline for fulminant Clostridioides difficile infection. Clin Microbiol Infect 2025; 31:315-318. [PMID: 39341413 DOI: 10.1016/j.cmi.2024.09.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2024] [Revised: 09/19/2024] [Accepted: 09/23/2024] [Indexed: 10/01/2024]
Affiliation(s)
| | - Chiara Iaria
- Infectious Diseases Unit, ARNAS Civico, Palermo, Italy
| | - Guido Granata
- Infectious Diseases Unit, INMI L. Spallanzani, Rome, Italy
| | - Antonio Cascio
- Infectious Diseases Unit, University Hospital P. Giaccone, Palermo, Italy
| | - Alberto Enrico Maraolo
- Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples 'Federico II,' Naples, Italy
| |
Collapse
|
|
2
|
Chen IW, Kao CL, Hung KC. Re: 'The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al. Clin Microbiol Infect 2025; 31:308-309. [PMID: 38331255 DOI: 10.1016/j.cmi.2024.01.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2024] [Accepted: 01/31/2024] [Indexed: 02/10/2024]
Affiliation(s)
- I-Wen Chen
- Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan
| | - Chia-Li Kao
- Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan
| | - Kuo-Chuan Hung
- Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan.
| |
Collapse
|
|
3
|
Alhammadi A, Alshawaf R, Chavda S, Ramondino S, Schuster M. Infectious Diseases: What You May Have Missed in 2023. Ann Intern Med 2024; 177:S37-S46. [PMID: 38621246 DOI: 10.7326/m24-0679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/17/2024] Open
Abstract
In 2023, published research on COVID-19 remains prominent. The aim of this article is to highlight important developments in infectious disease evidence unrelated to COVID-19 that were published in 2023. The literature was screened for sound new evidence relevant to internal medicine specialists and subspecialists whose focus of practice is not infectious diseases. The highlighted publications relate to various organisms and patient populations. One article provides insight into the updated guidelines for the diagnosis and management of infective endocarditis. Several articles address the management of sepsis and bacteremia: comparison of cefepime versus piperacillin-tazobactam, ceftobiprole for the treatment of complicated Staphylococcus aureus bacteremia, and early switch from intravenous to oral antibiotics in patients with gram-negative bacteremia. Another article examines differences in all-cause mortality in patients with Clostridioides difficile infection who receive different treatments. Additional articles provide evidence about the treatment of patients with HIV infection: the utility of preexposure prophylaxis to prevent HIV infection, the efficacy of pitavastatin in reducing cardiovascular disease, and the efficacy of dexamethasone for the treatment of tuberculous meningitis in persons with HIV.
Collapse
Affiliation(s)
- Amena Alhammadi
- Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (A.A., R.A., S.C., S.R.)
| | - Rasha Alshawaf
- Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (A.A., R.A., S.C., S.R.)
| | - Swati Chavda
- Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (A.A., R.A., S.C., S.R.)
| | - Sonya Ramondino
- Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (A.A., R.A., S.C., S.R.)
| | - Mindy Schuster
- University of Pennsylvania Perelman School of Medicine and Annals of Internal Medicine, Philadelphia, Pennsylvania (M.S.)
| |
Collapse
|
|
4
|
van Prehn J, Skinner AM, Krutova M, Guery B. Re: 'The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al. Clin Microbiol Infect 2024; 30:261-262. [PMID: 37865336 DOI: 10.1016/j.cmi.2023.10.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Accepted: 10/15/2023] [Indexed: 10/23/2023]
Affiliation(s)
- Joffrey van Prehn
- Department of Medical Microbiology, Leiden University Centre for Infectious Diseases, Leiden University Medical Centre (LUMC), Leiden, The Netherlands; ESCMID (European Society of Clinical Microbiology and Infectious Diseases) Study Group for Clostridioides Difficile (ESGCD), Basel, Switzerland; Guideline Committee 2021 Clostridioides Difficile Treatment Guidance Document of the European Study Group on Clostridioides Difficile, Switzerland.
| | - Andrew M Skinner
- Guideline Committee 2021 Focused Update Guidelines on Management of Clostridioides Difficile Infection in Adults Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA); George E. Wahlen Veteran Affairs Medical Centre, Salt Lake City, Utah and University of Utah School of Medicine, Salt Lake City, UT, USA
| | - Marcela Krutova
- ESCMID (European Society of Clinical Microbiology and Infectious Diseases) Study Group for Clostridioides Difficile (ESGCD), Basel, Switzerland; Guideline Committee 2021 Clostridioides Difficile Treatment Guidance Document of the European Study Group on Clostridioides Difficile, Switzerland; Department of Medical Microbiology, Charles University 2nd Medical Faculty and Motol University Hospital, Prague, Czech Republic
| | - Benoit Guery
- ESCMID (European Society of Clinical Microbiology and Infectious Diseases) Study Group for Clostridioides Difficile (ESGCD), Basel, Switzerland; Guideline Committee 2021 Clostridioides Difficile Treatment Guidance Document of the European Study Group on Clostridioides Difficile, Switzerland; Department of Medicine, Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland
| |
Collapse
|
|
5
|
Stabholz Y, Paul M. 'The Effect of Antibiotic Therapy for Clostridioides difficile Infection on Mortality and Other Patient-Relevant Outcomes' - Author's reply. Clin Microbiol Infect 2024; 30:263-264. [PMID: 37924971 DOI: 10.1016/j.cmi.2023.10.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Accepted: 10/29/2023] [Indexed: 11/06/2023]
Affiliation(s)
- Yoav Stabholz
- Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel; Department of Internal Medicine B, Rambam Health Care Campus, Haifa, Israel.
| | - Mical Paul
- Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel; Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
| |
Collapse
|
|
6
|
Ong SWX, Patel D, Reinblatt S, Tong SYC, Lee TC, McDonald EG, Daneman N. Choosing the right outcomes in infectious diseases clinical research-putting patients front and centre. Clin Microbiol Infect 2024; 30:10-14. [PMID: 37918512 DOI: 10.1016/j.cmi.2023.10.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Revised: 10/25/2023] [Accepted: 10/26/2023] [Indexed: 11/04/2023]
Affiliation(s)
- Sean W X Ong
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia; Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
| | - Devangi Patel
- Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada
| | | | - Steven Y C Tong
- Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia
| | - Todd C Lee
- Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, QC, Canada; Division of Infectious Diseases, McGill University Health Centre, Montréal, QC, Canada
| | - Emily G McDonald
- Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, QC, Canada; Division of General Internal Medicine, McGill University Health Centre, Montréal, QC, Canada
| | - Nick Daneman
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
| |
Collapse
|